Thomas Gaj

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Amyotrophic Lateral Sclerosis

Insulin Resistance

Top Venues

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

M Alejandra Zeballos C, Hayden J Moore, Tyler J Smith, Jackson E Powell, Najah S Ahsan, Sijia Zhang, Thomas Gaj
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins. Nature communications 14 (1) (2023)
Jackson E Powell, Colin K W Lim, Ramya Krishnan, Tristan X McCallister, Christian Saporito-Magriña, M Alejandra Zeballos C, Garrett D McPheron, Thomas Gaj
Targeted gene silencing in the nervous system with CRISPR-Cas13. Science advances 8 (3) (2022)
Thomas Gaj, David S Ojala, Freja K Ekman, Leah C Byrne, Prajit Limsirichai, David V Schaffer
In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Science advances 3 (12) (2017)